Europe has long had a biotechnology strategy. Over time, that work led to the Strategy on Bioeconomy, which the European ...

Unlike Trump’s first term, the pharmaceutical industry is in far more peril than it has ever been in, and the biotech industry needs to ask itself an important question: Where does it fit in ...

But today, Kendall has been reborn — as the glittering, glassy heart of America’s biotech industry. For many companies, Kendall Square’s status as a global center of biotechnology firms and ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...

LONDON, April 14 (Reuters) - Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling through a prolonged downturn, increasing ...

The Department of Pharmacy at the University of Naples Federico II hosted Biotech Future ... from the environment to industry. "It is very important to connect the world of industry and the ...

RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a ...

In this article, we will be taking a look at the 7 most profitable biotech stocks to buy right now. With improved market conditions, innovative breakthroughs, and more investor interest, the ...

In the biotech sector, the new year typically commences with a visit to the JP Morgan Healthcare Conference in San Francisco, one of the most significant annual events in our industry. It gathers ...

Biotech has a big footprint in Massachusetts, and according to a 2023 report, women make up less than 6% of leadership roles in the industry. We asked some women who are in those positions on how ...

Anticipation was in the air last January as biotechnology executives ... After a couple of brutal years, the industry — a pillar of the Massachusetts economy — seemed poised for a rebound.

to explore the dynamic landscape of the biotech industry. Throughout the conversation, Raifeld offers a unique perspective on the most significant trends shaping the sector today, with a ...